Use of immunotherapy in clinical management of genitourinary cancers – a review

Use of immunotherapy in clinical management of genitourinary cancers – a review

Checkpoint inhibitors targeting PD-1/PD-L1 and CTLA-4 have revolutionized oncologic care delivery, including clinical management of genitourinary malignancies. Despite significant associated improvement in patient outcomes, molecular heterogeneity of tumors, variable tumor engagement with the immune...

Full description

Bibliographic Details
Main Authors: Nataliya Mar, Edward Uchio, Arash Rezazadeh Kalebasty
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Genitourinary cancer
Immunotherapy
Checkpoint inhibitors
Urothelial carcinoma
Renal cell carcinoma
Prostate cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000545

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222000545

Similar Items